Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Bhatt Nailesh, Director. Insider active across 2 companies, notably Sonnet BioTherapeutics Holdings, Inc.. Aggregated, 6 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €5k. Activity tracked since 17 May 2023. The latest transaction was disclosed on 17 May 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
6 of 6 declarations
Nailesh Bhatt is a Board Member at Sonnet BioTherapeutics Holdings, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and oversight of operations. His experience in the industry is valuable to the board.